ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

ClinicalTrials.gov ID: NCT01283581

Public ClinicalTrials.gov record NCT01283581. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Exploratory Study of Objective Endpoints in Subjects With Acute Bacterial Skin and Skin Structure Infections Treated With Delafloxacin, Vancomycin, or Linezolid

Study identification

NCT ID
NCT01283581
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
256 participants

Conditions and interventions

Interventions

  • Delafloxacin Drug
  • Linezolid Drug
  • Vancomycin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2010
Primary completion
Oct 31, 2011
Completion
Oct 31, 2011
Last update posted
Oct 15, 2019

2011

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
30
Facility City State ZIP Site status
University of South Alabama Medical Center Mobile Alabama 36617
Drug Research and Analysis Corp Montgomery Alabama 36106
Southbay Pharma Research Buena Park California 90620
eStudySite Chula Vista California 91911
eStudySite La Mesa California 91942
HealthCare Partners Medical Group Los Angeles California 90015
eStudySite Oceanside California 92056
HealthCare Partners Medical Group Pasadena California 91105
Christiana Care Health Services Newark Delaware 19713
Riverside Clinical Research Edgewater Florida 32132
River City Clinical Research Jacksonville Florida 32207
Central Florida Internists Kissimmee Florida 34741
Central Florida Internists Medical Orlando Florida 32811
Central Florida Internists Saint Cloud Florida 34769
Ronald Barbour, MD Temple Terrace Florida 33617
Southeast Regional Research Group Columbus Georgia 31904
Atlanta Institute for Medical Research, Inc Decatur Georgia 30030
Southeast Regional Research Group Savannah Georgia 31406
University of Kansas Medical Center Kansas City Kansas 66160
Four Rivers Clinical Research, Inc Paducah Kentucky 42003
Medical Development Centers, LLC Baton Rouge Louisiana 70810
University of Missouri Health Care Columbia Missouri 65212
Mercury Street Medical Group, PLLC Butte Montana 59701
eStudySite Las Vegas Nevada 89109
South Jersey Infectious Disease Somers Point New Jersey 08244
Montefiore Medical Center The Bronx New York 10467
Remington-Davis, Inc. Columbus Ohio 43215
Ravi Kamepalli, MD Lima Ohio 45801
Health Concepts Rapid City South Dakota 57702
Jennifer Johnson-Caldwell, MD Houston Texas 77002
Alan Nolasco, MD Houston Texas 77005

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01283581, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01283581 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →